Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical ...

The PEGylated Proteins Market is primarily driven by the growing demand for effective drug delivery systems, particularly in the treatment of chronic diseases such as cancer, hepatitis, and rheumatoid ...

LBT Innovations Limited (AU:LBT) has released an update. LBT Innovations is making strides in the pharmaceutical environmental monitoring ...

The global environmental test equipment market is projected to be valued at USD 1.2 billion in 2023, with a growth rate of ...

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.

Cherry Bekaert (the Firm), a top accounting and advisory firm, is thrilled to announce the launch of its revamped website  The redesigned website boasts innovative new features that prioritize client ...

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

In a bid to streamline viral vector manufacturing, Thermo Fisher is charting another round of layoffs this year—and ...

Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...

Thermo Fisher Scientific (NYSE:TMO) is closing a facility as part of a shift in operations across Massachusetts.

Thermo Fisher Scientific Inc. has notified the state that it plans to lay off employees at two Massachusetts sites and close a third entirely.